In focus
Latest feed
A Bold New Chapter: Rare Ventures Launches with a $25 Million Bet on a Smarter Approach to Rare Disease Therapies
How a Personal Tragedy Drove Kiran Mazumdar‑Shaw to Pioneer Cancer Biosimilars at Biocon
Mandrake Bio Secures ₹16 Crore to Unlock the Future of AI-Driven Drug Discovery
Beyond the Name: Reed Jobs' Personal Crusade Against Cancer with Yosemite
